We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 2,746 results
  1. Molecular Pathways and Animal Models of Hypoplastic Left Heart Syndrome

    Hypoplastic left heart syndrome (HLHS) is a severe congenital heart disease (CHD) with underdevelopment of left-sided heart structures. While...
    Hisato Yagi, **nxiu Xu, ... Cecilia Lo in Congenital Heart Diseases: The Broken Heart
    Chapter 2024
  2. Multi-Modal in Vitro Experiments Mimicking the Flow Through a Mitral Heart Valve Phantom

    Purpose

    Fluid-structure interaction (FSI) models are more commonly applied in medical research as computational power is increasing. However,...

    Lea Christierson, Petter Frieberg, ... Nina Hakacova in Cardiovascular Engineering and Technology
    Article Open access 23 May 2024
  3. NPAS4 Polymorphisms Contribute to Coronary Heart Disease (CHD) Risk

    As genetic inheritance is an inevitable risk factor in the development of coronary heart disease (CHD), it is critical to identify the polymorphisms...

    Yu** Yan, **angli Yin, ... Gang Tian in Cardiovascular Toxicology
    Article 09 May 2022
  4. Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation

    Rivaroxaban, a direct factor Xa inhibitor, is widely used for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). The aim of...

    **ao-qin Liu, Yu-fei Zhang, ... Chun-lai Ma in Acta Pharmacologica Sinica
    Article 30 March 2022
  5. Single-cell analysis of adult human heart across healthy and cardiovascular disease patients reveals the cellular landscape underlying SARS-CoV-2 invasion of myocardial tissue through ACE2

    Background

    The distribution of ACE2 and accessory proteases (ANAD17 and CTSL) in cardiovascular tissue and the host cell receptor binding of severe...

    Cong Chen, Jie Wang, ... Jun Hu in Journal of Translational Medicine
    Article Open access 31 May 2023
  6. Morbidity of Scabies in Resource-Limited Countries: Rheumatic Heart Disease (RHD) and Post-Streptococcal Glomerulonephritis (APSGN)

    Scabies is one of the world’s most prevalent diseases, with approximately 147 million cases at any one time and an estimated annual incidence of 455...
    Anita Smith, Anna Schauer, ... Asha C. Bowen in Scabies
    Chapter 2023
  7. Bayesian Optimization-Based Inverse Finite Element Analysis for Atrioventricular Heart Valves

    Inverse finite element analysis (iFEA) of the atrioventricular heart valves (AHVs) can provide insights into the in-vivo valvular function, such as...

    Colton J. Ross, Devin W. Laurence, ... Chung-Hao Lee in Annals of Biomedical Engineering
    Article 21 November 2023
  8. Monogenic autoinflammatory disease-associated cardiac damage

    Introduction

    Autoinflammatory diseases (AIDs) constitute several disorders that are characterized by the presence of recurrent episodes of unprovoked...

    Qijiao Wei, Li Sun in Inflammation Research
    Article 10 August 2023
  9. The Individual and Combined Effects of Shear, Tension, and Flexure on Aortic Heart Valve Endothelial Cells in Culture

    Purpose

    The necessity of living engineered heart valves to treat patients with severe heart disease poses a challenge to tissue engineers. To reach...

    Nandini Deb, Carla M. R. Lacerda in Cardiovascular Engineering and Technology
    Article 22 November 2021
  10. A Fibrin-Thrombin Based In Vitro Perfusion System to Study Flow-Related Prosthetic Heart Valves Thrombosis

    Prosthetic heart valve (PHV) replacement has increased the survival rate and quality of life for heart valve-diseased patients. However, PHV...

    Yevgeniy Kreinin, Yahel Talmon, ... Netanel Korin in Annals of Biomedical Engineering
    Article Open access 08 March 2024
  11. Remifentanil but not sufentanil induces cardioprotection in human ischemic heart muscle in vitro

    Background

    Previous studies on animal models have suggested that δ-opioid receptor (OR) signaling is the primary pathway responsible for...

    Marcin Kunecki, Tomasz Oleksy, ... Wojciech Płazak in BMC Pharmacology and Toxicology
    Article Open access 20 April 2023
  12. An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score

    Heart failure with preserved ejection fraction (HFpEF) is under-recognized in clinical practice. Although a previously developed risk score, termed H 2 ...

    Yogesh N. V. Reddy, Rickey E. Carter, ... Barry A. Borlaug in Nature Medicine
    Article 12 July 2024
  13. Glial Activation, Mitochondrial Imbalance, and Akt/mTOR Signaling May Be Potential Mechanisms of Cognitive Impairment in Heart Failure Mice

    Heart failure (HF) is a major health burden worldwide, with approximately half of HF patients having a comorbid cognitive impairment (CI). However,...

    Yanan Wu, Kaiyi Zhou, ... Sheng Wang in Neurotoxicity Research
    Article 05 September 2023
  14. Managing patients with heart failure: contemporary real-world experience

    Objective

    Heart failure (HF) is a chronic disease with growing numbers of patients and a significant compromise in quality of life and high mortality....

    Muhammad Siddiqui, Christopher Ripplinger, ... Dakshina Murthy in BMC Research Notes
    Article Open access 10 February 2022
  15. Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review

    Fabry disease (FD) results from a lack of activity of the lysosomal enzyme α-Galactosidase A (α-Gal A), leading to the accumulation of...

    Julen Rodríguez-Castejón, Marina Beraza-Millor, ... Ana del Pozo-Rodríguez in Drug Delivery and Translational Research
    Article Open access 08 April 2024
  16. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

    The EMPEROR-Preserved trial showed that the sodium–glucose co-transporter 2 inhibitor empagliflozin significantly reduces the risk of cardiovascular...

    Stefan D. Anker, Javed Butler, ... Faiez Zannad in Nature Medicine
    Article Open access 05 December 2022
  17. A Novel Rheumatic Mitral Valve Disease Model with Ex Vivo Hemodynamic and Biomechanical Validation

    Purpose

    Rheumatic heart disease is a major cause of mitral valve (MV) dysfunction, particularly in disadvantaged areas and develo** countries. There...

    Matthew H. Park, Pearly K. Pandya, ... Y. Joseph Woo in Cardiovascular Engineering and Technology
    Article 08 August 2022
  18. Role of neopterin as an inflammatory biomarker in congestive heart failure with insights on effect of drug therapies on its level

    Inflammation has a major role in the pathogenesis of heart failure (HF). It triggers a cascade that leads to the release of pro-inflammatory...

    Gaidaa M. Dogheim, Mohamed T. Amralla, Rehab H. Werida in Inflammopharmacology
    Article Open access 25 July 2022
  19. Expression of Genes Encoding Nuclear Factors PPARγ, LXRβ, and RORα in Epicardial and Subcutaneous Adipose Tissues in Patients with Coronary Heart Disease

    The nuclear factors PPARγ, RORα, and LXRβ are involved in transcriptional control of adipogenesis and implicated in glucose and lipid metabolism. In...

    A. A. Panteleeva, N. D. Razgildina, ... V. V. Miroshnikova in Bulletin of Experimental Biology and Medicine
    Article 31 March 2021
  20. Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failure

    Background

    Studies focusing on sex differences in circulating proteins in patients with heart failure with reduced ejection fraction (HFrEF) are...

    Marie de Bakker, Teun B. Petersen, ... Isabella Kardys in Biology of Sex Differences
    Article Open access 17 May 2023
Did you find what you were looking for? Share feedback.